Humana Cares

whitePaper | September 26, 2022

As hospitals and private health offices nationwide slowly begin to emerge from the COVID-induced challenges posed over the last two years, there is a new understanding of, and necessity for, adaptable medical technology and practices.

whitePaper | September 19, 2022

Across all industries, and particularly in healthcare, companies are looking to tap into their data assets and drive intelligent decision making across the organization.

whitePaper | January 9, 2020

Radiation therapy is one of the most common treatments used to fight cancer in the U.S., with more than half of cancer patients receiving it either alone or in combination with other medical interventions.1 With the traditional approach to radiation therapy, the dose and schedule is tailored to the tumor type, location, and stage of growth, but only infrequently updated in light of changes after treatment starts. Experts in adaptive therapy are looking to deliver a more personalized treatment strategy guided by the individual patient’s needs.

whitePaper | June 3, 2022

With increased scrutiny from regulatory agencies, advocacy groups and the public for clinical trial transparency, sponsors are feeling the pressure to ramp up efforts to make their studies more accessible.

whitePaper | September 8, 2022

Artificial intelligence in healthcare has the potential to revolutionize clinical research and the monitoring and delivery of care

whitePaper | July 5, 2022

This whitepaper on atopic dermatitis patient recruitment explores the challenges faced by sponsors, CROs and study sites in enrolling sufficient numbers of patients for their clinical trials.